Option Care Health Inc
For the period ended Jun 30, 2024. Filed Jul 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 31, 2024
OPCH$31.65-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
(IN THOUSANDS)
| Six Months Ended June 30, | ||
|---|---|---|
| 2024 | 2023 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net income | $97,834 | $153,611 |
| Adjustments to reconcile net income to net cash provided by operations: | ||
| Depreciation and amortization expense | 30,802 | 30,801 |
| Non-cash operating lease costs | 12,503 | 9,334 |
| Deferred income taxes - net | 9,638 | 13,277 |
| Loss on extinguishment of debt | 377 | — |
| Amortization of deferred financing costs | 2,306 | 2,187 |
| Equity in earnings of joint ventures | (2,530) | (2,834) |
| Stock-based incentive compensation expense | 17,213 | 13,673 |
| Capital distribution from equity method investments | 750 | 2,500 |
| Other adjustments | (1,383) | 361 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (90,642) | (18,619) |
| Inventories | (7,417) | (38,643) |
| Prepaid expenses and other current assets | (1,745) | 654 |
| Accounts payable | 107,558 | 88,896 |
| Accrued compensation and employee benefits | (30,206) | (3,949) |
| Accrued expenses and other current liabilities | (6,986) | 24,805 |
| Operating lease liabilities | (11,459) | (7,754) |
| Other noncurrent assets and liabilities | 258 | (9,012) |
| Net cash provided by operating activities | 126,871 | 259,288 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Acquisition of property and equipment | (15,597) | (13,554) |
| Business acquisitions, net of cash acquired | — | (12,855) |
| Net cash used in investing activities | (15,597) | (26,409) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Stock-based compensation tax withholdings | (8,183) | (2,149) |
| Repayments of debt principal | (3,128) | (3,000) |
| Proceeds from issuance of debt | 49,959 | — |
| Deferred financing costs | (77) | — |
| Purchase of company stock | (118,122) | (75,000) |
| Other financing activities | 1,300 | (5,750) |
| Net cash used in financing activities | (78,251) | (85,899) |
| NET INCREASE IN CASH AND CASH EQUIVALENTS | 33,023 | 146,980 |
| Cash and cash equivalents - beginning of the period | 343,849 | 294,186 |
| CASH AND CASH EQUIVALENTS - END OF PERIOD | $376,872 | $441,166 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $36,070 | $33,991 |
| Cash paid for income taxes | $32,471 | $21,786 |
| Cash paid for operating leases | $14,360 | $13,231 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.